Effect of edaravone combined with ozagrel sodium on ADL and NIHSS score in patients with acute progressive cerebral infarction

Abstract

Objective To investigate the effect of edaravone combined with ozagrel sodium on ADL and NIHSS score in patients with acute progressive cerebral infarction. Methods 130 patients with acute progressive cerebral infarction admitted to our hospital from November 2017 to November 2018 were randomly divided into observation group and control group, 65 cases in each group. The observation group was treated with edaravone combined with ozagrel sodium, while the control group was treated with ozagrel sodium. The ADL score, NIHSS score, and total efficacy of the two groups of patients with acute progressive cerebral infarction were compared. Results The ADL score, NIHSS score of the observation group after treatment were (74.75±11.48) and (10.78±2.87), superior to the control group (P<0.05). The total effective rate of the observation group 98.46%, higher than that of the control group (86.15%) (P<0.05). Conclusion Edaravone combined with ozagrel sodium can effectively improve the prognosis of patients with acute progressive cerebral infarction, shorten the recovery time of neurological function, with higher clinical value. Key words: Acute progressive cerebral infarction; Sodium ozagrel; Edaravone; Influence observation